AN2 Therapeutics reported cash from operations of -$7.00M and free cash flow of -$7.00M for the quarter ended Jun 2026, up 7.9% year over year. This cash flow statement covers 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||
| Net Income | -6.91M | -7.57M | -7.66M | -10.11M | -11.30M | -11.85M | -16.04M | -16.60M | -18.18M | -18.82M | -16.62M | -14.44M | -12.75M | -7.52M | -10.65M | -6.46M | -9.35M | -8.71M | -10.03M | -8.18M | ||
| Share-based Compensation | 0.35M | 0.43M | 1.64M | 2.47M | 2.47M | 1.47M | 3.72M | 3.89M | 3.82M | 2.23M | 4.80M | 5.34M | 4.85M | 1.78M | 5.74M | 5.89M | 5.65M | 1.40M | 6.44M | 6.42M | ||
| Cash from Operations | -4.69M | -8.99M | -6.74M | -9.60M | -9.49M | -7.64M | -11.60M | -12.82M | -11.80M | -17.07M | -17.60M | -14.40M | -12.00M | -5.26M | -10.62M | -7.60M | -6.38M | -5.23M | -12.10M | -7.00M | ||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||
| Amortizatization of Intangibles | -0.02M | -0.02M | -0.00M | 0.07M | 0.24M | 0.38M | 0.43M | 0.46M | 0.65M | 1.31M | 1.09M | 0.89M | 0.73M | 0.57M | 0.44M | 0.30M | 0.21M | 0.12M | 0.08M | 0.09M | ||
| Change in Working Capital | ||||||||||||||||||||||
| Change in Account Payables | 0.71M | -0.95M | 1.55M | 0.44M | -0.17M | 0.68M | 1.42M | -0.41M | 1.65M | -2.11M | -0.24M | -0.55M | -0.17M | 1.61M | -0.24M | -0.96M | 0.11M | 0.80M | -0.41M | -1.00M | ||
| Change in Accured Expenses | 0.29M | -0.27M | -0.58M | 1.26M | 0.01M | 1.03M | -1.43M | 5.03M | 0.12M | 0.12M | -3.02M | 0.84M | 0.27M | -0.43M | -1.15M | -0.35M | -0.25M | -0.65M | -1.80M | 0.48M | ||
| Other Working Capital Changes | -0.61M | 1.04M | 0.57M | 2.08M | -0.63M | -0.33M | -0.74M | 1.17M | -0.02M | 0.62M | -1.11M | 0.80M | 0.32M | -0.81M | -0.65M | 1.80M | -2.51M | -0.16M | 0.27M | -0.72M | ||
| Investing Activities | ||||||||||||||||||||||
| Change in Acquisitions & Divestments | 22.25M | 14.97M | 13.50M | 20.09M | 23.50M | 24.90M | 21.00M | 22.75M | 20.25M | 26.29M | 29.05M | 28.50M | 17.50M | 31.50M | 17.50M | 10.00M | 15.50M | 10.99M | 10.00M | |||
| Cash from Investing Activities | -6.99M | 6.25M | 13.98M | -39.49M | -2.32M | 6.05M | 10.89M | 7.88M | -62.46M | 0.42M | 26.29M | 16.46M | 18.72M | -6.88M | 9.19M | 5.83M | 6.11M | 7.17M | 8.29M | -3.66M | ||
| Financing Activities | ||||||||||||||||||||||
| Other financing activities | 0.00M | 63.20M | 7.18M | -0.01M | 0.23M | 0.04M | -0.01M | 0.04M | 0.04M | |||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||
| Net Shares Issued and Repurchased | 0.07M | 1.24M | 0.92M | 1.22M | 0.93M | 1.70M | 1.03M | 1.22M | 1.01M | |||||||||||||
| Net Equity Issued and Repurchased | -4.50M | 0.20M | 0.12M | 0.02M | 0.04M | 0.05M | ||||||||||||||||
| Misc. | ||||||||||||||||||||||
| Cash from Financing Activities | -0.24M | -0.97M | 63.19M | 7.18M | -0.01M | 0.20M | 19.05M | 66.07M | -0.32M | 0.35M | 0.02M | 0.07M | 0.05M | 37.33M | 1.49M | |||||||
| Change in Cash | -11.92M | -3.72M | 70.42M | -41.90M | -11.81M | -1.58M | -0.51M | 14.10M | -8.20M | -16.97M | 9.05M | 2.08M | 6.74M | -12.15M | -1.37M | -1.76M | -0.22M | 1.94M | 33.55M | -9.17M | ||
| Free Cash Flow | -4.69M | -8.99M | -6.74M | -9.60M | -9.49M | -7.64M | -11.60M | -12.82M | -11.80M | -17.07M | -17.60M | -14.40M | -12.00M | -5.26M | -10.62M | -7.60M | -6.38M | -5.23M | -12.10M | -7.00M | ||
| Net Cash Flow | -11.92M | -3.72M | 70.42M | -41.90M | -11.81M | -1.58M | -0.51M | 14.10M | -8.20M | -16.97M | 9.04M | 2.06M | 6.74M | -12.14M | -1.37M | -1.76M | -0.22M | 1.94M | 33.52M | -9.17M |